{
  "company_number": "SC651132",
  "name": "TAY Therapeutics Limited",
  "url": "/company/SC651132",
  "status": "Active",
  "is_active": true,
  "company_type": "Private Limited Company",
  "incorporated_on": "2020-01-10",
  "dissolved_on": null,
  "sic_codes": [
    "72110"
  ],
  "registered_address": {
    "id": 1443327,
    "url": "/address/1443327",
    "line1": "LIFE SCIENCES INNOVATION HUB",
    "line2": "5 JAMES LINDSAY PLACE",
    "post_town": "DUNDEE",
    "county": "",
    "country": "SCOTLAND",
    "postcode": "DD1 5JJ"
  },
  "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/SC651132",
  "previous_names": [
    {
      "name": "In4derm Ltd",
      "ceased_on": "2022-05-04"
    }
  ],
  "care_of": "",
  "po_box": "",
  "country_of_origin": "United Kingdom",
  "accounts": {
    "next_due": "2026-10-31",
    "last_made_up": "2025-01-31",
    "category": "UNAUDITED ABRIDGED",
    "filings": [
      {
        "url": "/company/SC651132/accounts/2026-01-31",
        "made_up_date": "2026-01-31",
        "period_start": "2026-01-31",
        "period_end": "2026-01-31",
        "entity_name": "TAY Therapeutics Limited",
        "dormant": false,
        "average_employees": "12.00",
        "tangible_fixed_assets": null,
        "debtors": "571487.00",
        "cash_bank_in_hand": "1684712.00",
        "current_assets": "2256199.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "2166031.00",
        "total_assets_less_current_liabilities": "3156031.00",
        "net_assets_liabilities": "3156031.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "246.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Bulk_Data-2026-07-07.zip"
      },
      {
        "url": "/company/SC651132/accounts/2025-01-31",
        "made_up_date": "2025-01-31",
        "period_start": "2025-01-31",
        "period_end": "2025-01-31",
        "entity_name": "TAY Therapeutics Limited",
        "dormant": false,
        "average_employees": "12.00",
        "tangible_fixed_assets": "18542.00",
        "debtors": "191329.00",
        "cash_bank_in_hand": "3067171.00",
        "current_assets": "3258500.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "3170538.00",
        "total_assets_less_current_liabilities": "3189080.00",
        "net_assets_liabilities": "3189080.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "246.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-June2025.zip"
      },
      {
        "url": "/company/SC651132/accounts/2024-01-31",
        "made_up_date": "2024-01-31",
        "period_start": "2024-01-31",
        "period_end": "2024-01-31",
        "entity_name": "TAY Therapeutics Limited",
        "dormant": false,
        "average_employees": "8.00",
        "tangible_fixed_assets": "42441.00",
        "debtors": "112125.00",
        "cash_bank_in_hand": "3159884.00",
        "current_assets": "3272009.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "2995181.00",
        "total_assets_less_current_liabilities": "3037622.00",
        "net_assets_liabilities": "3037622.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "246.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-June2024.zip"
      },
      {
        "url": "/company/SC651132/accounts/2023-01-31",
        "made_up_date": "2023-01-31",
        "period_start": "2023-01-31",
        "period_end": "2023-01-31",
        "entity_name": "TAY Therapeutics Limited",
        "dormant": false,
        "average_employees": "5.00",
        "tangible_fixed_assets": "61566.00",
        "debtors": "577745.00",
        "cash_bank_in_hand": "1914571.00",
        "current_assets": "2492316.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "2048186.00",
        "total_assets_less_current_liabilities": "2109752.00",
        "net_assets_liabilities": "2109752.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "246.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-July2023.zip"
      },
      {
        "url": "/company/SC651132/accounts/2022-01-31",
        "made_up_date": "2022-01-31",
        "period_start": "2022-01-31",
        "period_end": "2022-01-31",
        "entity_name": "TAY Therapeutics Limited",
        "dormant": false,
        "average_employees": "4.00",
        "tangible_fixed_assets": "314.00",
        "debtors": "184046.00",
        "cash_bank_in_hand": "2622443.00",
        "current_assets": "2806489.00",
        "creditors_due_within_one_year": "274824.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "2531665.00",
        "total_assets_less_current_liabilities": "2531979.00",
        "net_assets_liabilities": "2531979.00",
        "called_up_share_capital": "246.00",
        "profit_loss_account_reserve": "-151448.00",
        "shareholder_funds": "246.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-June2022.zip"
      },
      {
        "url": "/company/SC651132/accounts/2021-01-31",
        "made_up_date": "2021-01-31",
        "period_start": "2021-01-31",
        "period_end": "2021-01-31",
        "entity_name": "In4derm Ltd",
        "dormant": false,
        "average_employees": "3.00",
        "tangible_fixed_assets": null,
        "debtors": null,
        "cash_bank_in_hand": null,
        "current_assets": "1005141.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "970811.00",
        "total_assets_less_current_liabilities": "970811.00",
        "net_assets_liabilities": "970811.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "970811.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2021.zip"
      }
    ],
    "pdf_only_filings": [],
    "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/SC651132/filing-history"
  },
  "confirmation_statement": {
    "next_due": "2026-08-06",
    "last_made_up": "2025-07-23"
  },
  "officers": [],
  "psc": [
    {
      "name": "Dr Christopher Andrew Woodland",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/892284",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-25-to-50-percent",
        "voting-rights-25-to-50-percent"
      ],
      "notified_on": "2020-01-10",
      "ceased_on": "2021-01-25",
      "nationality": "British",
      "country_of_residence": "United Kingdom",
      "source": "snapshot"
    }
  ],
  "external_links": [],
  "provenance": {
    "source": "snapshot",
    "first_seen_at": "2026-07-05T12:35:35.811816+00:00",
    "last_seen_snapshot": "2026-07-01",
    "retrieved_at": "2026-07-26T06:14:34.267126+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House."
}